Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTSL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CAPN13 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NUF2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SLC12A6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EIF1AD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HBZ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BBC3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | MOB1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GP1BB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |